A research team has discovered that by using a new method of "atomic spray painting," they can tweak the atomic structure of lead-free potassium niobate in order to enhance its ferroelectric ...

With maximum funding of up to $150,000, you’ll likely be limited to financing a used semi truck or a new basic model that doesn’t come with all the bells and whistles. Funding in as little as ...

Brianna is a contributing writer for InStyle covering all things beauty. She is known for discovering the coolest niche beauty brands from around the world, really good hair day tips, and best-in ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

Semiconductor stocks are under pressure on Monday as Wall Street deciphers the latest news coming out of China around DeepSeek, which is a Chinese AI research lab that released its open-source AI ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

Australian Open 2025 women's singles semi-finals Highlights: Iga Swiatek has been knocked out of the Australian Open. Madison Keys beats Swiatek 10-8 in the tiebreaker of the final set to reach her ...

Madison Keys celebrates winning a match at the 2025 Australian Open. / Mike Frey-Imagn Images American tennis star Madison Keys completed a huge comeback victory over World No. 2 Iga Swiatek in ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

"I'm April Wilkerson, a DIY enthusiast with a passion for creative projects and hands-on building." Tom Hanks ‘storms out’ of SNL 50th anniversary concert Mac McClung Makes NBA All-Star ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...